Definitive Contract 75N93020C00059

Award Date 9/30/20
Potential Completion Date 9/29/24
Potential Value $2.2M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
New York, NY 10032, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,583,631.14 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to The Trustees of Columbia University in the City of New York. The contract is for the development of a "HIGH THROUGHPUT BIODOSIMETRY USING A FULLY AUTOMATED DICENTRIC ASSAY ON COMMERCIAL HIGH-CONTENT SCREENING PLATFORMS". This work aims to advance high-throughput capabilities for assessing radiation...
This is a definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to The Trustees of Columbia University in the City of New York (Health Sciences Division), a private university and non-profit organization. The $637,675 contract is to adapt Columbia University's platform with micro-sized human tissues into a modular immune chip, by bioengineering adult-like human bone marrow, lung, and heart tissues from...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $60,000 firm fixed price purchase order to The Trustees of Columbia University in the City of New York, doing business as Columbia University's Health Sciences Division and sponsored projects administration division. Columbia University will provide TBDCapSeq services in tissues for transcriptomic analysis of 120 samples, continuing previous work with NIAID...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The $94,591.05 delivery order is for biomedical research services and does not have a set-aside designation. The contract is a type of Indefinite Delivery Vehicle (IDV) that allows the CDC to continuously...
This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The $3,859,771.82 cost-no-fee contract is for biomedical research and exploratory activities related to the NHLBI's mission. The contract does not have a set-aside designation. Columbia University, a leading research...
This federal contract award, with an ID of 75N93024P01130, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which is a firm fixed-price purchase order, is for TBDC CAPSEQ-TRANCRIPTOME ANALYSIS SERVICE and has a ceiling value of $41,250.00. The contract does not have a set-aside designation, indicating open competition....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,041,443.00 definitive contract to The Regents of the University of Colorado, doing business as University of Colorado-Denver, to conduct research for "CHARACTERIZING AND IMPROVING HUMANIZED IMMUNE SYSTEM MOUSE MODELS (IMM-HIS)". This contract was not set aside and is expected to be completed by February 28, 2025. The University of Colorado-Denver is a major public research university that regularly...
This is a $373,073 firm fixed-price contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to The Trustees of Columbia University in the City of New York (Columbia University) to support "Computational Thinking to Support Clinicians and Biomedical Scientists". The contract is funded through the American Recovery and Reinvestment Act (ARRA) and has a completion date of September 26,...
This is a definitive contract awarded by the National Institutes of Health (NIH) to The Trustees of Columbia University in the City of New York, operating as Columbia University, for a "Clinical Center for the Lung Volume Reduction" project. The contract has a ceiling value of $122,817.36 and a completion date of June 30, 2005. This contract is not associated with a set-aside program. Columbia University, a renowned private research institution, has a long history of collaborating with...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services. The $288,983.05 delivery order contract was awarded to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to provide services related to protocol review, protocol development, and consultation in the female topic area. The contract does not have a set-aside...

The Trustees of Columbia University in the City of New York, doing business as Columbia University's Health Sciences Division, was awarded a $2.2 million definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to characterize and improve humanized immune system mouse models. This contract was awarded under the 2019 NIAID Omnibus Broad Agency Announcement seeking proposals for medical countermeasures, therapeutics, and vaccines research across four areas, including radiation/nuclear countermeasure development and therapeutics for antibiotic resistant bacteria designated as threats by the CDC. Over its four year period of performance ending in September 2024, Columbia University will conduct research to enhance humanized immune system mouse models, contributing to NIAID's efforts to develop medical solutions targeting infectious disease threats. There is no set-aside designation associated with this contract award.

Generated 12/29/23, 3:23 PM